SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-21-059157
Filing Date
2021-04-30
Accepted
2021-04-30 17:01:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm2114515-2_424b3.htm 424B3 179280
2 GRAPHIC tm2113175d1-img_003.jpg GRAPHIC 20962
3 GRAPHIC tm2113175d1-img_001.jpg GRAPHIC 33832
4 GRAPHIC tm2113175d1-img_002.jpg GRAPHIC 15806
  Complete submission text file 0001104659-21-059157.txt   272579
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-255311 | Film No.: 21879319
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences